Mineralys Therapeutics (MLYS) Enterprise Value
Price: $13.40
Market Cap: $869.34M
Avg Volume: 1.09M
Market Cap: $869.34M
Avg Volume: 1.09M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Mineralys Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 500.89M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 597.52M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $12.31, with 49.96M shares outstanding.
- The company has 114.09M in cash and cash equivalents and - in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$500.89M
Market Cap
$614.98M
Total Debt
$-
Cash and Equivalents
$114.09M
Historical Enterprise Value
Mineralys Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $500.89M | -1.01% | $12.31 | 49.96M | $614.98M | $114.09M | $- |
| September 30, 2024 | $505.99M | -5.03% | $12.11 | 49.82M | $603.26M | $97.27M | $- |
| June 30, 2024 | $532.81M | 7.72% | $12.17 | 49.36M | $600.67M | $67.86M | $- |
| March 31, 2024 | $494.64M | 67.39% | $13.03 | 44.90M | $585.06M | $90.42M | $- |
| December 31, 2023 | $295.50M | 136.36% | $8.6 | 40.09M | $344.80M | $49.30M | $- |
| September 30, 2023 | $125.02M | -75.55% | $9.51 | 41.11M | $390.91M | $265.89M | $- |
| June 30, 2023 | $511.30M | 104.88% | $14.99 | 40.86M | $612.44M | $101.14M | $- |
| March 31, 2023 | $249.56M | -62.51% | $15.66 | 24.76M | $387.80M | $138.25M | $- |
| December 31, 2022 | $665.70M | -1462.47% | $18.44 | 40.86M | $753.40M | $87.70M | $- |
| September 30, 2022 | $-48.86M | -114.21% | $18.44 | 5.18K | $95.54K | $48.95M | $- |
| June 30, 2022 | $343.80M | -2.99% | $18.44 | 18.64M | $343.80M | $- | $- |
| March 31, 2022 | $354.41M | -50.05% | $18.44 | 18.64M | $343.80M | $-10.61M | $- |
| December 31, 2021 | $709.59M | - | $18.44 | 39.06M | $720.20M | $10.61M | $- |
Related Metrics
Explore detailed financial metrics and analysis for MLYS.